Last week, the city council of Arcata, California, decriminalized psychedelic substances. The measure, which was approved in a unanimous vote, will make the distribution, growing and possession of entheogenic substances such as ayahuasca and psilocybin among the lowest law-enforcement priorities in the city.
Researchers at the University of Alabama at Birmingham, Johns Hopkins University and New York University were awarded nearly $4 million in funding to study the efficacy of psilocybin.
The second-largest bank in the U.S. is shutting down the account of a research institute that’s federally authorized to cultivate and study Schedule I substances like marijuana and psilocybin mushrooms.
A new study argues that there might be a link between classic psychedelic use (DMT, LSD, “magic” mushroom, etc.) and lower odds of heart disease.
Activists in Oakland, California are hoping to expand upon the city’s current psychedelics decriminalization ordinance by creating a community-based model through which people could legally purchase entheogenic substances from local producers.
The Drug Enforcement Administration (DEA) is proposing a dramatic increase in the legal production of marijuana and psychedelics like psilocybin, LSD, MDMA and DMT to be used in research next year,
Mindset Pharma announced that under its Co-operative Psychedelics Evaluation Platform (COPE) further developed its first-generation psychedelics benchmarking data by establishing standard pharmacokinetic, brain penetration, and drug discrimination data and protocols across LSD, psilocybin, and 5-MeO-DMT.
Scientific American reports on three paths to rescheduling of psilocybin. The first is legislative, going through congress. The second route is administrative, via Biden and the DEA (least likely route). And the third route is judicial, suing the DEA after the second route fails.
COMPASS Pathways announces the appointment of eminent psychiatrist, Professor Guy Goodwin, as Chief Medical Officer.
Emotional Intelligence Ventures (Ei.Ventures) announced that it’s raising $50 million via a ‘regulation A+’ public stock offering. The funding will take it from being a subsidiary of Orthogonal Thinker to a public company. The announcement was made in March 2021, with fundraising still ongoing in February 2022. Emotional Intelligence Ventures (Ei.Ventures or Ei), Inc, the …